MBD following kidney transplantation is common and characterized by loss of bone volume
and mineralization abnormalities, often leading to low turnover bone disease. Although …

Mineral and bone diseases (MBD) are common in patients with chronic kidney disease who
undergo kidney transplantation. The incidence, types and severity of MBD vary according to …

Aim: Vascular calcification, a major complication of chronic kidney disease (CKD), refers to
the mineralization of vascular smooth muscle cells (VSMCs), resulting from a phenotypic …

Aim: Vascular calcification, an independent risk factor for cardiovascular disease in patients
with chronic kidney disease (CKD), refers to the mineralization of vascular smooth muscle …

Background. Anemia and mineral and bone disorders (MBD) are both important and
common complications in kidney transplant recipients. Studies in patients with chronic …

Purpose Several observational studies have indicated that vitamin D receptor activators
(VDRA), including paricalcitol, are associated with greater survival in maintenance …

Background: Kidney transplantation is associated with various biochemical abnormalities
such as changes in serum blood level of sodium (Na), potassium (K), calcium (Ca), and …

Background: Optimal levels of intact parathyroid hormone (iPTH) in the post-transplant
period are not known due to insufficient data. Therefore, we aimed to describe secondary …

Introduction: The persistence of mineral metabolism disorders after renal transplant (RT)
appears to possess a negative impact over graft and patient's survival. Objectives: To …

Background: Significant variations in postoperative levels of parathyroid hormone (PTH),
calcium and phosphate exist after renal transplantation, but whether they affect allograft …